The 1st Congress of Cardiovascular Prevention in Pre-Elderly and Elderly Individuals (CPPEI 2016) is dedicated to the latest research developments in cardiovascular medicine, diabetes, prevention of hypertension, coronary artery disease, metabolic syndrome, cardiac arrhythmias, heart failure, acute coronary syndromes and stroke in Pre-Elderly and Elderly Individuals.
The 1st Congress of Cardiovascular Prevention in Pre-Elderly and Elderly Individuals (CPPEI 2016) covers topics such as:
- Primary prevention – Statins
- Cardiovascular prevention – Atherogenic dyslipidemia
- Risk stratification – Drug-related adverse events
- Secondary prevention – Lipid lowering therapy
- Optimal blood pressure – Functional foods
- Hypertension research – Nutraceuticals
- Hypertension complications – Epidemiological studies
- Blood pressure goals – Randomized controlled trials
- Combination therapy – New drugs
- Antihypertensive therapy – Cohort studies
- Arrythmias – Left ventricular dysfunction
- Polypills – Heart failure
- Ventricular arrhythmias – End stage renal disease
- Supraventricular arrhythmias – Chronic kidney disease
- Antiplatelet therapy – Myocardial infarction
- Anticoagulant therapy – Acute coronary syndrome
- Diabetes – Coronary artery bypass grafting
- Anti-arrythmic therapy – Percutaneous coronary intervention
- Antidiabetic therapy – Frailty
- Incretin-based therapy – New PCI techniques
- Overweight/obesity – Cachexia/sarcopenia
- Risk factors – Falls
- Biomarkers – Quality of life
